
Chris Benton, MD, provides an overview of first-line treatment options for patients with lower-risk myelodysplastic syndromes (LR-MDS).

Your AI-Trained Oncology Knowledge Connection!

Chris Benton, MD, is a hematologist-oncologist at Rocky Mountain Cancer Centers.